Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
50.41
-1.13 (-2.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
July 24, 2024
On Wednesday, major U.S. indices closed significantly lower. The Dow Jones Industrial Average fell 1.25% to 39,853.87.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q2 2024
July 24, 2024
VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Viking Therapeutics Stock Climbs On Q2 EPS Beat
July 24, 2024
Viking Therapeutics shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the key figures from the report:
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,600 Today
July 23, 2024
Via
Benzinga
Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.
July 22, 2024
Eli Lilly is still a smart pick, but these two stocks could grow more in the near term.
Via
The Motley Fool
Smart Money Is Betting Big In VKTX Options
July 18, 2024
Via
Benzinga
Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
July 05, 2024
Via
Benzinga
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
July 01, 2024
Via
Benzinga
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
They're small now, but these stocks could grow much larger.
Via
The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks With Breakout Potential
July 19, 2024
Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements
Via
InvestorPlace
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
This biotech stock fits the profile of a potentially big winner to a T.
Via
The Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
July 18, 2024
These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late.
Via
InvestorPlace
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest...
Via
Benzinga
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde.
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Roche released early-stage data on its oral weight-loss drug.
Via
Investor's Business Daily
Is Viking Therapeutics the Best Biotech Stock for You?
July 17, 2024
Let's look beyond the hype the company is generating this year.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment.
Via
InvestorPlace
Is Viking Therapeutics Stock Running Out of Steam?
July 11, 2024
Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today.
Via
The Motley Fool
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics
July 10, 2024
Both competitors have promising lead programs, and enough cash, too.
Via
The Motley Fool
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
This pharma company is posting double-digit revenue growth.
Via
The Motley Fool
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches.
Via
InvestorPlace
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into now.
Via
InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Via
InvestorPlace
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
July 01, 2024
It's a tough act to follow.
Via
The Motley Fool
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
June 30, 2024
While their share prices have traveled different paths recently, the similarity between the two companies is striking.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.